Clinical Trials in Chicago

Showing 11521-11540 of 17,609 trials

Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone

NCT02027961

The purpose of this study is to determine the maximum tolerated dose and characterize the safety profile of durvalumab (MEDI4736) in combination with dabrafenib and trametinib or with trametinib alone in participants with metastatic or unresectable melanoma with BRAF-mutation positive or wild-type (WT) BRAF, respectively.

Melanoma

MedImmune LLC68 participantsStarted Dec 2013

Scottsdale, Arizona, United States • Los Angeles, California, United States • San Francisco, California, United States +8 more locations

TERMINATED2.2 miles

The Chimerix CMX001 Registry

NCT02167685

The prospective observational study is to establish a registry database to evaluate the potential impact of prior treatment with CMX001 on the long-term incidence of specific events, such as outcomes, late CMV and other Double-stranded DNA virus associated events, s well as survival rates in subjects previously enrolled in selected clinical studies of CMX001. Each Registry participant will be followed for a period of approximately 3 years from their enrollment in the Registry.

OutcomesSurvival Rates

Jazz Pharmaceuticals550 participantsStarted Jan 2014

La Jolla, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +48 more locations

Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone

The Chimerix CMX001 Registry

Find Trials by Condition in Chicago

The Effects of Aspirin and Acetaminophen on the Stomach in Healthy Volunteers

Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia

Effect of Ivabradine in Stage D HF/Cardiogenic Shock Patients on Dobutamine

ST266 Versus Standard Care In Treating Partial Thickness Burns

The PROOF Study: The PICC Related Obstruction Of Flow Study

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

Validation of Brain Function Assessment Algorithm for mTBI/Concussion in College Athletes

Objective Brain Function Assessment of mTBI/Concussion in High School Athletes

Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML

Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction

SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)

PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib

Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

Sterol and Isoprenoid Disease Research Consortium: Smith-Lemli-Opitz Syndrome

Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain

Occult Gastrointestinal Bleeding in Non-pulsatile Left Ventricular Assist Device(VAD)Patients

A Study to Compare the Safety and Efficacy of Romosozumab (AMG 785) Versus Placebo in Men With Osteoporosis

Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma